A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects
Clinical trial NCT07327697 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07327697
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2026-07-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.